Brian Olshansky

ORCID: 0000-0002-6044-045X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Syncope and Autonomic Disorders
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Effects of Exercise
  • Cardiovascular Function and Risk Factors
  • Cardiomyopathy and Myosin Studies
  • Heart rate and cardiovascular health
  • Cardiac Imaging and Diagnostics
  • Blood Pressure and Hypertension Studies
  • Venous Thromboembolism Diagnosis and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • ECG Monitoring and Analysis
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrest and Resuscitation
  • Cardiac Structural Anomalies and Repair
  • Botulinum Toxin and Related Neurological Disorders
  • Art Education and Development
  • Neurological disorders and treatments
  • Lipoproteins and Cardiovascular Health
  • Pharmacology and Obesity Treatment
  • Respiratory and Cough-Related Research

University of Iowa Hospitals and Clinics
2016-2025

University of Iowa
2016-2025

Iowa City VA Medical Center
2025

Mercy Hospital
2014-2023

University of Iowa Health Care
2012-2023

CHI Health Mercy Council Bluffs
2014-2023

Cooper Green Mercy Hospital
2014-2023

Mercy Medical Center
2015-2023

Louisiana State University in Shreveport
2023

Covenant Medical Center
2023

The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient, where necessary patient's guardian or carer.It is also professional's verify rules regulations...

10.1093/eurheartj/ehp298 article EN European Heart Journal 2009-08-27

The implantable cardioverter–defibrillator (ICD) is highly effective in reducing mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are frequent, with potential adverse effects.

10.1056/nejmoa1211107 article EN New England Journal of Medicine 2012-11-06

Background —The purpose of this study was to evaluate the safety and efficacy a temperature-controlled radiofrequency catheter ablation system. Methods Results patient population included 1050 patients who had undergone atrioventricular nodal reentrant tachycardia (AVNRT), an accessory pathway (AP), or junction (AVJ). Ablation successful in 996 patients. The probability success highest among AVJ, lowest AP, between for AVNRT. A major complication occurred 32 Four variables predicted (AVJ,...

10.1161/01.cir.99.2.262 article EN Circulation 1999-01-19

comparative and descriptive studies, case series, cohort systematic reviews, expert opinion.Only selected references are cited.The Task Force recognizes the need for objective, independent Evidence Review Committees (ERCs) that include methodologists, epidemiologists, clinicians, biostatisticians who systematically survey, abstract, assess evidence to address key clinical questions posed in PICOTS format (P=population, I=intervention, C=comparator, O=outcome, T=timing, S=setting). 4,5...

10.1161/cir.0000000000000311 article EN Circulation 2015-09-24

Background— Tachycardia-induced cardiomyopathy is a reversible cause of heart failure. We hypothesized that although left ventricular ejection fraction measurements normalize after rate or rhythm control in patients with tachycardia-induced cardiomyopathy, recurrent tachycardia may have abrupt and deleterious consequences. Methods Results— Patients developed over years were evaluated treated. Tachycardia episodes outcomes assessed. Twenty-four identified. All had NYHA functional class III...

10.1161/01.cir.0000135472.28234.cc article EN Circulation 2004-06-29

The risks of sports participation for implantable cardioverter-defibrillator (ICD) patients are unknown.Athletes with ICDs (age, 10-60 years) participating in organized (n=328) or high-risk (n=44) were recruited. Sports-related and clinical data obtained by phone interview medical records. Follow-up occurred every 6 months. ICD shock outcomes adjudicated 2 electrophysiologists. Median age was 33 years (89 subjects <20 age); 33% female. Sixty competitive athletes (varsity/junior...

10.1161/circulationaha.112.000447 article EN Circulation 2013-05-20

Coronavirus disease 2019 (COVID-19) is a global pandemic that wreaking havoc on the health and economy of much human civilization. Electrophysiologists have been impacted personally professionally by this catastrophe. In joint article from representatives Heart Rhythm Society, American College Cardiology, Association, we identify potential risks exposure to patients, allied healthcare staff, industry representatives, hospital administrators. We also describe impact COVID-19 cardiac...

10.1016/j.hrthm.2020.03.028 article EN other-oa Heart Rhythm 2020-04-01

Major clinical centers in Sweden have witnessed an inflow of patients with chronic symptoms following initial outpatient care for coronavirus disease-2019 (COVID-19) infection, suggestive postural orthostatic tachycardia syndrome. This report presents the first case series 3 Swedish diagnosed syndrome more than months after primary COVID-2019 infections. (Level Difficulty: Intermediate.)

10.1016/j.jaccas.2021.01.009 article EN cc-by-nc-nd JACC Case Reports 2021-03-11

Importance Whether vigorous intensity exercise is associated with an increase in risk of ventricular arrhythmias individuals hypertrophic cardiomyopathy (HCM) unknown. Objective To determine whether engagement increased for and/or mortality HCM. The a priori hypothesis was that participants engaging activity were not more likely to have arrhythmic event or die than those who reported nonvigorous activity. Design, Setting, and Participants This investigator-initiated, prospective cohort...

10.1001/jamacardio.2023.1042 article EN JAMA Cardiology 2023-05-17
Coming Soon ...